Details for New Drug Application (NDA): 208555
✉ Email this page to a colleague
NDA 208555 describes RIVAROXABAN, which is a drug marketed by Alkem Labs Ltd, Lupin Ltd, Aiping Pharm Inc, Alembic, Apotex, Ascent Pharms Inc, Aurobindo Pharma Ltd, Biocon Pharma, Breckenridge, Dr Reddys, Invagen Pharms, Macleods Pharms Ltd, MSN, Regcon Holdings, Sciegen Pharms, Sunshine, and Taro, and is included in nineteen NDAs. It is available from seventeen suppliers. Additional details are available on the RIVAROXABAN profile page.
The generic ingredient in RIVAROXABAN is rivaroxaban. There are thirty-five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the rivaroxaban profile page.
The generic ingredient in RIVAROXABAN is rivaroxaban. There are thirty-five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the rivaroxaban profile page.
Summary for 208555
| Tradename: | RIVAROXABAN |
| Applicant: | Lupin Ltd |
| Ingredient: | rivaroxaban |
| Patents: | 0 |
Pharmacology for NDA: 208555
| Mechanism of Action | Factor Xa Inhibitors |
Medical Subject Heading (MeSH) Categories for 208555
Suppliers and Packaging for NDA: 208555
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| RIVAROXABAN | rivaroxaban | TABLET;ORAL | 208555 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-709 | 68180-709-06 | 30 TABLET, FILM COATED in 1 BOTTLE (68180-709-06) |
| RIVAROXABAN | rivaroxaban | TABLET;ORAL | 208555 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-709 | 68180-709-09 | 90 TABLET, FILM COATED in 1 BOTTLE (68180-709-09) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
| Approval Date: | Mar 3, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | May 14, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
| Approval Date: | May 14, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
